CareDx (CDNA) Misses Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to CareDx (CDNA) Misses Q1 EPS by 1c
May 12, 2015 4:05 PM EDT
Quarterly Revenue Growth of 22% Year Over Year
Cell-Free DNA Technology Advances With the Release of Clinical Data and the Start of a Clinical Trial
BRISBANE, Calif., May 12, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value, non-invasive surveillance solutions for transplant recipients, today reported financial results for the three months ended March 31, 2015.
2015 highlights year to date:
Total revenues for the first quarter...
More
May 12, 2015 4:05 PM EDT
Quarterly Revenue Growth of 22% Year Over Year
Cell-Free DNA Technology Advances With the Release of Clinical Data and the Start of a Clinical Trial
BRISBANE, Calif., May 12, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value, non-invasive surveillance solutions for transplant recipients, today reported financial results for the three months ended March 31, 2015.
2015 highlights year to date:
Total revenues for the first quarter...
More
